The Multi-Organ Future of GLP-1: Beyond Obesity & Diabetes
GLP-1 therapies started as treatment for diabetes and obesity. Now they are changing care in cardiology, hepatology, nephrology, neurology, and oncology. From reducing fibrosis in MASH to penetrating the blood-brain barrier for Alzheimer’s, the landscape is expanding rapidly, and new research data continues to emerge. Recent approvals reflect this shift. Zepbound now treats sleep apnea. […]
The Protein Innovation Map Your Competitors Are Already Using
Last 18 months have changed the rules for building protein platforms for bars, extruded snacks, or baked formats. Microalgae, bacterial fermentation, and fungal proteins have moved beyond experimental trials. Several are now hitting commercial performance benchmarks that directly challenge pea and soy. What follows is a technical and commercial breakdown of the protein systems already […]